Xofigo (radium RA 223 dichloride)

Ended Awarded Last action

Contract number
VA24717F0673
Awardee
Awarding agency
Obligated
$213,438

Award facts

Contract value 100% obligated
$213,438.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Decatur, GA 30033, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00001 -$31,001
Original award $244,439

About this award

This federal contract award is for the delivery of Xofigo (radium Ra 223 dichloride), a specialized pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The order has a ceiling value of $213,438.96 and was placed through the VA's National Acquisition Center. The contract is a firm fixed-price delivery order with no set-aside designation, allowing Bayer Healthcare Pharmaceuticals Inc. to provide this critical radiopharmaceutical medication to support healthcare programs for veterans. This contract award is part of Bayer's broader federal contract portfolio, which includes a $840 million multiple-award FSS contract with the VA and an $18.2 million Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical.

Quick answers

Who was awarded contract VA24717F0673?

VA24717F0673 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on January 11, 2017.

How much is contract VA24717F0673 worth?

The government has obligated $213,438 on VA24717F0673. Its current value, with exercised options, is $213,439.

Is contract VA24717F0673 an order under another contract?

Yes. VA24717F0673 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA24717F0673 competed?

The extent of competition for VA24717F0673 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award